Literature DB >> 20567619

Balancing potential quality-of-life benefits against the risk of lethal late recurrence with bladder-preserving surgery.

Laurence Klotz.   

Abstract

Keywords:  Bladder cancer; bladder-sparing approach; radical cystectomy

Year:  2010        PMID： 20567619      PMCID： PMC2880903          DOI： 10.3747/co.v17i3.544

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  4 in total

1.  Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.

Authors:  Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Donald S Kaufman; Michael P Hagan; Niall M Heney; Howard M Sandler
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

Review 2.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321

Review 3.  Neoadjuvant chemotherapy for invasive bladder cancer.

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 4.  Adjuvant chemotherapy for invasive bladder cancer (individual patient data).

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.